From an immunological viewpoint, MTs are known to be produced in states of inflammation, in response to cytokines (including Il-6) and, by regulating redox status, they can protect the host from some of the toxic effect of ROS, which are produced by neutrophils and are known to be implicated in the immunopathogenesis of COVID-19. Here, IL6 is linked to COVID-19.